Search

everythinglearnresearchcommunity

for

Search:↓

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Adipose tissue-derived exosomes may help regrow hair in alopecia areata.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Oil A formulation with Baricitinib shows promise for treating alopecia areata by promoting hair growth.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

The guideline provides recommendations for managing alopecia areata effectively.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Alopecia areata involves unique activation of certain immune cells.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

The gut microbiome affects the development of alopecia areata.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

JAK inhibitors might help treat alopecia areata.

NXC736 significantly reduced hair loss in mice with alopecia areata.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

The Fas/FasL pathway may play a role in alopecia areata.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.